secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tenon Medical, Inc. (TNON)
CIK:        0001560293
Form:       8-K
Filed at:   2024-08-27T23:59:59+00:00
Accession:  0001213900-24-072982
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenon Medical appoints Kevin Williamson as CFO effective Sept 3, 2024
---------------------------------------------------------------------

- Appointed Kevin Williamson as CFO, effective Sept 3, 2024, succeeding retiring CFO Steve Van Dick.
- Compensation: $315,000 base salary, bonus up to 30% of base, RSU of 50,000 shares with 3-year vesting.
- Williamson most recently CFO at Accelus Inc., prior roles at NuVasive; holds B.S. and MBA.
- Company cites upcoming catalysts: full enrollment of post-market clinical trial for Catamaran SI Joint Fusion System.
- Severance: 100% of base salary for 12 months if terminated without cause.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1560293/000121390024072982/0001213900-24-072982-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1560293/000121390024072982/ea0212316-8k_tenon.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-072982

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer